

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.65211009 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.65211009 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.11179874 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.03998604 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.03998604 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.03998604 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 6.03998604 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 6.03998604 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 6.03998604 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.91753376 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 5.89936694 |
| 12 | response to type I interferon (GO:0034340) | 5.65617138 |
| 13 | type I interferon signaling pathway (GO:0060337) | 5.61592072 |
| 14 | cellular response to type I interferon (GO:0071357) | 5.61592072 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 5.56313480 |
| 16 | response to interferon-alpha (GO:0035455) | 5.39158608 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19913975 |
| 18 | NIK/NF-kappaB signaling (GO:0038061) | 4.67186713 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.66658799 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.54740809 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.49458064 |
| 22 | response to host immune response (GO:0052572) | 4.49458064 |
| 23 | negative T cell selection (GO:0043383) | 4.41068412 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.33817626 |
| 25 | positive regulation of interferon-beta production (GO:0032728) | 4.28841641 |
| 26 | cellular response to virus (GO:0098586) | 4.24831873 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22335519 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.21260721 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.13703025 |
| 30 | response to host (GO:0075136) | 4.13703025 |
| 31 | response to host defenses (GO:0052200) | 4.13703025 |
| 32 | I-kappaB phosphorylation (GO:0007252) | 4.11604254 |
| 33 | response to peptidoglycan (GO:0032494) | 4.01624016 |
| 34 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.97847126 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.97715502 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.96754188 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95496475 |
| 38 | cellular response to interferon-alpha (GO:0035457) | 3.94028632 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.87471765 |
| 40 | negative regulation of viral genome replication (GO:0045071) | 3.84943267 |
| 41 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.84679876 |
| 42 | regulation of RIG-I signaling pathway (GO:0039535) | 3.83615421 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82628843 |
| 44 | positive T cell selection (GO:0043368) | 3.81842105 |
| 45 | response to interleukin-15 (GO:0070672) | 3.81193282 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.68581430 |
| 47 | detection of other organism (GO:0098543) | 3.67415433 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.64389240 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.62425706 |
| 50 | leukocyte aggregation (GO:0070486) | 3.60150267 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.59438603 |
| 52 | natural killer cell mediated immunity (GO:0002228) | 3.59438603 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.59323720 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56607578 |
| 55 | cellular extravasation (GO:0045123) | 3.55516088 |
| 56 | T cell selection (GO:0045058) | 3.53506803 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 3.47818302 |
| 58 | thymic T cell selection (GO:0045061) | 3.43707211 |
| 59 | detection of bacterium (GO:0016045) | 3.41672491 |
| 60 | activated T cell proliferation (GO:0050798) | 3.41274060 |
| 61 | detection of external biotic stimulus (GO:0098581) | 3.40384691 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.39597684 |
| 63 | positive regulation of humoral immune response (GO:0002922) | 3.36308444 |
| 64 | cellular response to interleukin-15 (GO:0071350) | 3.36302729 |
| 65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.29672394 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.28596164 |
| 67 | defense response to virus (GO:0051607) | 3.28561971 |
| 68 | cellular response to interferon-beta (GO:0035458) | 3.27507402 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25143481 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.24592033 |
| 71 | regulation of interferon-beta production (GO:0032648) | 3.23877515 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21559533 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.20703258 |
| 74 | histone H3-K36 demethylation (GO:0070544) | 3.20286487 |
| 75 | T cell migration (GO:0072678) | 3.19554010 |
| 76 | microglial cell activation (GO:0001774) | 3.16906912 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.16237352 |
| 78 | cellular response to ethanol (GO:0071361) | 3.15257416 |
| 79 | positive regulation of T cell cytokine production (GO:0002726) | 3.14557148 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 3.13369047 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 3.12454091 |
| 82 | regulation of necroptotic process (GO:0060544) | 3.11354355 |
| 83 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.09573588 |
| 84 | cellular response to interferon-gamma (GO:0071346) | 3.09558879 |
| 85 | negative regulation of cell killing (GO:0031342) | 3.06613610 |
| 86 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.06613610 |
| 87 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.06471877 |
| 88 | tolerance induction (GO:0002507) | 3.06333771 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05804720 |
| 90 | regulation of tolerance induction (GO:0002643) | 3.04949155 |
| 91 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.04531055 |
| 92 | regulation of B cell differentiation (GO:0045577) | 3.03448362 |
| 93 | negative regulation of interleukin-12 production (GO:0032695) | 3.02501611 |
| 94 | positive regulation of interleukin-12 production (GO:0032735) | 3.02219936 |
| 95 | interferon-gamma production (GO:0032609) | 3.02102706 |
| 96 | positive regulation of response to biotic stimulus (GO:0002833) | 3.01320269 |
| 97 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97647757 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.97259072 |
| 99 | mature B cell differentiation (GO:0002335) | 2.95249960 |
| 100 | detection of biotic stimulus (GO:0009595) | 2.94851170 |
| 101 | positive regulation of tolerance induction (GO:0002645) | 2.93678525 |
| 102 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93536064 |
| 103 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93233528 |
| 104 | negative regulation of type I interferon production (GO:0032480) | 2.91572259 |
| 105 | interferon-gamma secretion (GO:0072643) | 2.91442018 |
| 106 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91047284 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89433729 |
| 108 | positive regulation of type 2 immune response (GO:0002830) | 2.88914544 |
| 109 | germinal center formation (GO:0002467) | 2.87509923 |
| 110 | response to interferon-beta (GO:0035456) | 2.85533101 |
| 111 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84912769 |
| 112 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.84756502 |
| 113 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.84623537 |
| 114 | defense response to protozoan (GO:0042832) | 2.84311754 |
| 115 | myeloid cell activation involved in immune response (GO:0002275) | 2.81576054 |
| 116 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.79413259 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 2.76563294 |
| 118 | B cell mediated immunity (GO:0019724) | 2.75465334 |
| 119 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.74811066 |
| 120 | regulation of response to interferon-gamma (GO:0060330) | 2.74291866 |
| 121 | negative regulation of innate immune response (GO:0045824) | 2.74288715 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71800534 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.71025170 |
| 124 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71008284 |
| 125 | cellular response to exogenous dsRNA (GO:0071360) | 2.69713051 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.69683795 |
| 127 | hepatocyte apoptotic process (GO:0097284) | 2.69136191 |
| 128 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.67039083 |
| 129 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66901116 |
| 130 | negative regulation of adaptive immune response (GO:0002820) | 2.66273154 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66206672 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.65386838 |
| 133 | macrophage activation (GO:0042116) | 2.65373086 |
| 134 | response to protozoan (GO:0001562) | 2.64533377 |
| 135 | granulocyte activation (GO:0036230) | 2.63231701 |
| 136 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.62402290 |
| 137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62142769 |
| 138 | response to interferon-gamma (GO:0034341) | 2.61603107 |
| 139 | negative thymic T cell selection (GO:0045060) | 2.60507045 |
| 140 | negative regulation of viral process (GO:0048525) | 2.60305179 |
| 141 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59795112 |
| 142 | neutrophil activation (GO:0042119) | 2.59355785 |
| 143 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.59139631 |
| 144 | cytokine secretion (GO:0050663) | 2.58290990 |
| 145 | JAK-STAT cascade (GO:0007259) | 2.56401335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.57788722 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.92164562 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.54557147 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.41074706 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.38653217 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.68269434 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.47785893 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30807596 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25004850 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16582263 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10143547 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76995827 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.76007633 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.69966834 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64986231 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58652860 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54016999 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41706573 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.40236842 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15396596 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98592119 |
| 22 | * MAF_26560356_Chip-Seq_TH1_Human | 1.96915919 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93067657 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90312684 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84646297 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83070668 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81087468 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79212275 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.77684995 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71414030 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68976361 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66925013 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66463404 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61870518 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.60075814 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55229369 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53515032 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47591484 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.45213702 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44901696 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43986035 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43736912 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42879683 |
| 44 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.38778944 |
| 45 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.34120082 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30744883 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29884636 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23931021 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23464660 |
| 50 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18733351 |
| 51 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17682951 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17390906 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15536599 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14663226 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14411919 |
| 56 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14328290 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14311965 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14076945 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12836454 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12809625 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.12022573 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11719112 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11509851 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11231699 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10779084 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09173749 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08475329 |
| 68 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07104395 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06302194 |
| 70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05375393 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04964724 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03472168 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02210308 |
| 74 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.01940035 |
| 75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00766151 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99709635 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99453483 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97849407 |
| 79 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97616228 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96627162 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95967543 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95139080 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94766478 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94766478 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93322632 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89083953 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88028602 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86486635 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84743560 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84306696 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84152515 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84060337 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83615227 |
| 94 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.82828612 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82571094 |
| 96 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81748545 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80923142 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78712225 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78213051 |
| 100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77844894 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77069381 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76054772 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75062251 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74098631 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73850215 |
| 106 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73785459 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73307176 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72998236 |
| 109 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.72673354 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71535115 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71517300 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.71426127 |
| 113 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.71003873 |
| 114 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69918222 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69152128 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69004563 |
| 117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.68939418 |
| 118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.68683776 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 0.68142022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.91893971 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.49444697 |
| 3 | MP0000685_abnormal_immune_system | 3.12486690 |
| 4 | MP0009785_altered_susceptibility_to | 3.02398441 |
| 5 | MP0003303_peritoneal_inflammation | 2.95484834 |
| 6 | MP0001790_abnormal_immune_system | 2.88107178 |
| 7 | MP0005387_immune_system_phenotype | 2.88107178 |
| 8 | MP0003436_decreased_susceptibility_to | 2.76196810 |
| 9 | MP0001800_abnormal_humoral_immune | 2.57165990 |
| 10 | MP0005025_abnormal_response_to | 2.55139677 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.47275523 |
| 12 | MP0004510_myositis | 2.42735011 |
| 13 | MP0002419_abnormal_innate_immunity | 2.42186792 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.40624394 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.40368036 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.36836847 |
| 17 | MP0002723_abnormal_immune_serum | 2.30621798 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.30263096 |
| 19 | MP0004947_skin_inflammation | 2.19455600 |
| 20 | MP0005451_abnormal_body_composition | 2.12889072 |
| 21 | MP0005671_abnormal_response_to | 2.10535782 |
| 22 | MP0009278_abnormal_bone_marrow | 2.10346624 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.09034038 |
| 24 | MP0003724_increased_susceptibility_to | 2.05526963 |
| 25 | MP0001819_abnormal_immune_cell | 2.04545313 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.03860543 |
| 27 | MP0006082_CNS_inflammation | 2.03439865 |
| 28 | MP0002006_tumorigenesis | 2.02045924 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.00620322 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.84880903 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.75113391 |
| 32 | MP0010307_abnormal_tumor_latency | 1.72513891 |
| 33 | MP0002398_abnormal_bone_marrow | 1.69979041 |
| 34 | MP0004381_abnormal_hair_follicle | 1.68693395 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.64262542 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.64262542 |
| 37 | MP0000716_abnormal_immune_system | 1.62509916 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.59006346 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.57449483 |
| 40 | MP0002405_respiratory_system_inflammati | 1.56684013 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.56289382 |
| 42 | MP0003091_abnormal_cell_migration | 1.55594647 |
| 43 | MP0009840_abnormal_foam_cell | 1.54472677 |
| 44 | MP0008469_abnormal_protein_level | 1.52701421 |
| 45 | MP0003448_altered_tumor_morphology | 1.51904034 |
| 46 | MP0001853_heart_inflammation | 1.47297564 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.46832712 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.46815797 |
| 49 | MP0004883_abnormal_blood_vessel | 1.46578641 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.45449894 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.43979447 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.42789680 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.41458972 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.39409909 |
| 55 | MP0002396_abnormal_hematopoietic_system | 1.39061747 |
| 56 | MP0001873_stomach_inflammation | 1.36733028 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.36656988 |
| 58 | MP0002254_reproductive_system_inflammat | 1.35687855 |
| 59 | MP0002429_abnormal_blood_cell | 1.33247917 |
| 60 | MP0003690_abnormal_glial_cell | 1.32595441 |
| 61 | MP0002722_abnormal_immune_system | 1.30205593 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.28659428 |
| 63 | MP0000604_amyloidosis | 1.28649281 |
| 64 | MP0009764_decreased_sensitivity_to | 1.26995719 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.23340440 |
| 66 | MP0001958_emphysema | 1.21987888 |
| 67 | MP0008057_abnormal_DNA_replication | 1.21046808 |
| 68 | MP0008260_abnormal_autophagy | 1.18720117 |
| 69 | MP0000371_diluted_coat_color | 1.17245248 |
| 70 | MP0005310_abnormal_salivary_gland | 1.16773088 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.16084271 |
| 72 | MP0003045_fibrosis | 1.13553296 |
| 73 | MP0005023_abnormal_wound_healing | 1.13388138 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 1.12852618 |
| 75 | MP0005164_abnormal_response_to | 1.12755007 |
| 76 | MP0009763_increased_sensitivity_to | 1.09392572 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 1.08548192 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.07534242 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.06232918 |
| 80 | MP0002332_abnormal_exercise_endurance | 1.05802216 |
| 81 | MP0002009_preneoplasia | 1.04274819 |
| 82 | MP0000858_altered_metastatic_potential | 1.02775429 |
| 83 | MP0005083_abnormal_biliary_tract | 1.00460391 |
| 84 | MP0000343_altered_response_to | 0.95697616 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.95281350 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.92815315 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86040509 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.84994632 |
| 89 | MP0008004_abnormal_stomach_pH | 0.84991893 |
| 90 | MP0003075_altered_response_to | 0.83476983 |
| 91 | MP0000609_abnormal_liver_physiology | 0.82571040 |
| 92 | MP0001915_intracranial_hemorrhage | 0.82431294 |
| 93 | MP0005621_abnormal_cell_physiology | 0.80891202 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.78141280 |
| 95 | MP0002933_joint_inflammation | 0.77675960 |
| 96 | MP0004130_abnormal_muscle_cell | 0.77416548 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.76053521 |
| 98 | MP0005360_urolithiasis | 0.75828722 |
| 99 | MP0001663_abnormal_digestive_system | 0.74931514 |
| 100 | MP0003866_abnormal_defecation | 0.73340505 |
| 101 | MP0000733_abnormal_muscle_development | 0.72760628 |
| 102 | MP0006054_spinal_hemorrhage | 0.72276339 |
| 103 | MP0000249_abnormal_blood_vessel | 0.72109947 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.70491411 |
| 105 | MP0002132_abnormal_respiratory_system | 0.69981856 |
| 106 | MP0005390_skeleton_phenotype | 0.68501685 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.68292184 |
| 108 | MP0003828_pulmonary_edema | 0.68144839 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.67392924 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.67218742 |
| 111 | MP0002168_other_aberrant_phenotype | 0.66140254 |
| 112 | MP0005166_decreased_susceptibility_to | 0.64937692 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.64679016 |
| 114 | MP0005257_abnormal_intraocular_pressure | 0.64150523 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.63492428 |
| 116 | MP0001851_eye_inflammation | 0.63074003 |
| 117 | MP0001881_abnormal_mammary_gland | 0.62736602 |
| 118 | MP0000598_abnormal_liver_morphology | 0.62438974 |
| 119 | MP0009115_abnormal_fat_cell | 0.60458615 |
| 120 | MP0003795_abnormal_bone_structure | 0.59944312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.58312781 |
| 2 | Chronic otitis media (HP:0000389) | 4.53430713 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.47194024 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.41558712 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.29821532 |
| 6 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.14161893 |
| 7 | Recurrent viral infections (HP:0004429) | 4.00520506 |
| 8 | Myositis (HP:0100614) | 3.96687102 |
| 9 | Orchitis (HP:0100796) | 3.82332795 |
| 10 | Optic neuritis (HP:0100653) | 3.70938132 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.70938132 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67759818 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.62982488 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.50894189 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.44944815 |
| 16 | Nasal polyposis (HP:0100582) | 3.37420267 |
| 17 | Vasculitis (HP:0002633) | 3.29875324 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25007444 |
| 19 | Periodontitis (HP:0000704) | 3.24228341 |
| 20 | Hematochezia (HP:0002573) | 3.20080971 |
| 21 | Recurrent skin infections (HP:0001581) | 3.16474074 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 3.10353905 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.07047710 |
| 24 | Osteolytic defects of the hand bones (HP:0009699) | 3.02446791 |
| 25 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.02446791 |
| 26 | Arterial thrombosis (HP:0004420) | 2.98273321 |
| 27 | Myocardial infarction (HP:0001658) | 2.96067041 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90812378 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90812378 |
| 30 | Gingival bleeding (HP:0000225) | 2.90259644 |
| 31 | Gingivitis (HP:0000230) | 2.86921974 |
| 32 | Encephalitis (HP:0002383) | 2.86134820 |
| 33 | Colitis (HP:0002583) | 2.84976481 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.83050994 |
| 35 | Pulmonary infiltrates (HP:0002113) | 2.80686269 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.79313300 |
| 37 | Prostate neoplasm (HP:0100787) | 2.79136142 |
| 38 | Basal ganglia calcification (HP:0002135) | 2.78781917 |
| 39 | Pustule (HP:0200039) | 2.78159388 |
| 40 | Porencephaly (HP:0002132) | 2.73208153 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.68496396 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 2.63379893 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.59030218 |
| 44 | Absent frontal sinuses (HP:0002688) | 2.57791034 |
| 45 | Premature loss of primary teeth (HP:0006323) | 2.55739774 |
| 46 | Increased IgE level (HP:0003212) | 2.54581512 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.52215942 |
| 48 | Thick nail (HP:0001805) | 2.51925358 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.48206403 |
| 50 | Emphysema (HP:0002097) | 2.47884893 |
| 51 | Stomatitis (HP:0010280) | 2.47539896 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.42105958 |
| 53 | Frequent falls (HP:0002359) | 2.40378398 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.39696191 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 2.36407739 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.35743561 |
| 57 | Cellulitis (HP:0100658) | 2.35708286 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.34792282 |
| 59 | Osteomyelitis (HP:0002754) | 2.34611810 |
| 60 | Viral hepatitis (HP:0006562) | 2.34606220 |
| 61 | Plagiocephaly (HP:0001357) | 2.32801669 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30988146 |
| 63 | Tetraparesis (HP:0002273) | 2.29889036 |
| 64 | Hemoptysis (HP:0002105) | 2.26890225 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.24038977 |
| 66 | Leukocytosis (HP:0001974) | 2.22115022 |
| 67 | Abnormality of T cell number (HP:0011839) | 2.22107765 |
| 68 | Pulmonary embolism (HP:0002204) | 2.21997282 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.19927011 |
| 70 | Chronic sinusitis (HP:0011109) | 2.19913770 |
| 71 | Eosinophilia (HP:0001880) | 2.17520010 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.16458112 |
| 73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16321631 |
| 74 | Urticaria (HP:0001025) | 2.15851826 |
| 75 | T lymphocytopenia (HP:0005403) | 2.14378460 |
| 76 | Loss of speech (HP:0002371) | 2.13161494 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.12903482 |
| 78 | Abnormality of T cell physiology (HP:0011840) | 2.12524841 |
| 79 | Peritonitis (HP:0002586) | 2.08692753 |
| 80 | Lymphopenia (HP:0001888) | 2.08230727 |
| 81 | Esophageal varix (HP:0002040) | 2.07357636 |
| 82 | IgM deficiency (HP:0002850) | 2.07126504 |
| 83 | IgA deficiency (HP:0002720) | 2.06129542 |
| 84 | Chronic diarrhea (HP:0002028) | 2.05418946 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04629033 |
| 86 | Increased IgM level (HP:0003496) | 2.04168818 |
| 87 | Cerebral aneurysm (HP:0004944) | 2.04034627 |
| 88 | Abnormality of the peritoneum (HP:0002585) | 2.03139904 |
| 89 | Agammaglobulinemia (HP:0004432) | 2.02681610 |
| 90 | Spinal cord lesions (HP:0100561) | 2.02024250 |
| 91 | Syringomyelia (HP:0003396) | 2.02024250 |
| 92 | Mitral stenosis (HP:0001718) | 2.01498967 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.00024517 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 1.98433570 |
| 95 | Nephritis (HP:0000123) | 1.96803479 |
| 96 | Epistaxis (HP:0000421) | 1.95943461 |
| 97 | Bone pain (HP:0002653) | 1.94902036 |
| 98 | Meningitis (HP:0001287) | 1.93685591 |
| 99 | Abnormality of the endocardium (HP:0004306) | 1.91820851 |
| 100 | Abnormal platelet volume (HP:0011876) | 1.91258195 |
| 101 | Gangrene (HP:0100758) | 1.89025673 |
| 102 | Vertebral compression fractures (HP:0002953) | 1.87142424 |
| 103 | Chest pain (HP:0100749) | 1.86381790 |
| 104 | Skin ulcer (HP:0200042) | 1.85917890 |
| 105 | Pathologic fracture (HP:0002756) | 1.84786433 |
| 106 | Gastrointestinal stroma tumor (HP:0100723) | 1.84228004 |
| 107 | Restrictive lung disease (HP:0002091) | 1.83437158 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83429477 |
| 109 | Acute hepatic failure (HP:0006554) | 1.83309054 |
| 110 | Verrucae (HP:0200043) | 1.83185194 |
| 111 | Papilloma (HP:0012740) | 1.83185194 |
| 112 | Joint swelling (HP:0001386) | 1.83085222 |
| 113 | Hypoplasia of the thymus (HP:0000778) | 1.82144124 |
| 114 | Conjunctival telangiectasia (HP:0000524) | 1.81972095 |
| 115 | Increased mean platelet volume (HP:0011877) | 1.81378220 |
| 116 | Abnormality of the pleura (HP:0002103) | 1.81368585 |
| 117 | Cheilitis (HP:0100825) | 1.80434292 |
| 118 | Broad face (HP:0000283) | 1.80304366 |
| 119 | Dislocated radial head (HP:0003083) | 1.77331570 |
| 120 | Malnutrition (HP:0004395) | 1.75761145 |
| 121 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74494147 |
| 122 | Obstructive lung disease (HP:0006536) | 1.74494147 |
| 123 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.73861613 |
| 124 | Granulocytopenia (HP:0001913) | 1.73544232 |
| 125 | Persistence of primary teeth (HP:0006335) | 1.73103671 |
| 126 | Abnormality of T cells (HP:0002843) | 1.72369298 |
| 127 | Fatigue (HP:0012378) | 1.71954986 |
| 128 | Glomerulopathy (HP:0100820) | 1.71873566 |
| 129 | Large earlobe (HP:0009748) | 1.71768165 |
| 130 | Distal lower limb amyotrophy (HP:0008944) | 1.71523136 |
| 131 | Anorexia (HP:0002039) | 1.71519906 |
| 132 | IgG deficiency (HP:0004315) | 1.71033495 |
| 133 | Thrombocytosis (HP:0001894) | 1.70918559 |
| 134 | Ulnar bowing (HP:0003031) | 1.70382173 |
| 135 | Papilledema (HP:0001085) | 1.64778524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.77437209 |
| 2 | MAP3K14 | 3.77355865 |
| 3 | IKBKE | 3.76111551 |
| 4 | JAK3 | 3.38706453 |
| 5 | JAK1 | 3.34064094 |
| 6 | TBK1 | 3.16189581 |
| 7 | FGFR4 | 2.89680775 |
| 8 | MAP3K13 | 2.77115934 |
| 9 | MAP4K1 | 2.71160641 |
| 10 | KIT | 2.67971447 |
| 11 | PRPF4B | 2.41898590 |
| 12 | IRAK3 | 2.20516682 |
| 13 | TTN | 2.17615317 |
| 14 | RIPK4 | 2.14704758 |
| 15 | CDK12 | 2.10400526 |
| 16 | IRAK4 | 2.10107424 |
| 17 | ERN1 | 2.01739840 |
| 18 | FGFR3 | 1.96122806 |
| 19 | IKBKB | 1.90540141 |
| 20 | BLK | 1.78849548 |
| 21 | EPHB1 | 1.71170855 |
| 22 | MAP3K10 | 1.57150764 |
| 23 | TAOK3 | 1.52637231 |
| 24 | CHUK | 1.48368708 |
| 25 | CSK | 1.44343302 |
| 26 | CAMK1D | 1.41306860 |
| 27 | CDC42BPA | 1.33147136 |
| 28 | PTK6 | 1.32618208 |
| 29 | HCK | 1.28578881 |
| 30 | STK10 | 1.27343049 |
| 31 | ZAP70 | 1.25124032 |
| 32 | MARK2 | 1.24052551 |
| 33 | TXK | 1.22836229 |
| 34 | EPHA3 | 1.22632976 |
| 35 | RIPK1 | 1.22453606 |
| 36 | JAK2 | 1.20025281 |
| 37 | TNK2 | 1.17116200 |
| 38 | CSF1R | 1.17077323 |
| 39 | LCK | 1.11570960 |
| 40 | SIK2 | 1.11353857 |
| 41 | TRIB3 | 1.06432581 |
| 42 | PKN2 | 1.05243292 |
| 43 | BMPR2 | 1.03430703 |
| 44 | MARK3 | 1.03139047 |
| 45 | SIK1 | 1.02572124 |
| 46 | SYK | 1.02152296 |
| 47 | PIK3CG | 0.97452451 |
| 48 | MAP3K1 | 0.96746061 |
| 49 | CAMK1G | 0.95928930 |
| 50 | WNK1 | 0.91168664 |
| 51 | SGK2 | 0.90279604 |
| 52 | BTK | 0.88639731 |
| 53 | TGFBR2 | 0.87743062 |
| 54 | TAOK1 | 0.86851752 |
| 55 | RPS6KA4 | 0.86772661 |
| 56 | TRPM7 | 0.85917431 |
| 57 | PIM1 | 0.84541815 |
| 58 | STK3 | 0.81703405 |
| 59 | FGR | 0.80281966 |
| 60 | FES | 0.78814478 |
| 61 | CAMKK2 | 0.78233929 |
| 62 | LRRK2 | 0.73668631 |
| 63 | MAP3K2 | 0.73371447 |
| 64 | NEK9 | 0.72491801 |
| 65 | STK4 | 0.72476974 |
| 66 | ITK | 0.72144372 |
| 67 | PTK2B | 0.71500512 |
| 68 | BMX | 0.70592760 |
| 69 | MAPK7 | 0.69756371 |
| 70 | EGFR | 0.69349343 |
| 71 | YES1 | 0.68619971 |
| 72 | MAP3K6 | 0.68451447 |
| 73 | EIF2AK2 | 0.68283798 |
| 74 | RET | 0.65807770 |
| 75 | CDK6 | 0.65088144 |
| 76 | GRK7 | 0.61836834 |
| 77 | STK38 | 0.60916681 |
| 78 | LYN | 0.60100076 |
| 79 | KSR2 | 0.59924448 |
| 80 | PDGFRB | 0.59772139 |
| 81 | BRD4 | 0.59578237 |
| 82 | MTOR | 0.59457316 |
| 83 | GRK6 | 0.58872663 |
| 84 | EEF2K | 0.58799246 |
| 85 | SMG1 | 0.57528582 |
| 86 | TEC | 0.55870543 |
| 87 | CAMKK1 | 0.55558334 |
| 88 | MAP2K3 | 0.53112006 |
| 89 | IRAK1 | 0.53067754 |
| 90 | MATK | 0.51958299 |
| 91 | MAPK12 | 0.51321658 |
| 92 | MAP3K5 | 0.50590341 |
| 93 | MAPK11 | 0.50204962 |
| 94 | PRKD2 | 0.49414029 |
| 95 | ICK | 0.49208706 |
| 96 | DAPK2 | 0.48853354 |
| 97 | ABL1 | 0.48322875 |
| 98 | FLT3 | 0.48104074 |
| 99 | SGK3 | 0.47600135 |
| 100 | FRK | 0.47223935 |
| 101 | ERBB2 | 0.45540479 |
| 102 | PRKCQ | 0.43838961 |
| 103 | TYRO3 | 0.43055270 |
| 104 | IRAK2 | 0.42030134 |
| 105 | CDK4 | 0.41821314 |
| 106 | SGK223 | 0.41795588 |
| 107 | NLK | 0.41425826 |
| 108 | NUAK1 | 0.39408552 |
| 109 | ALK | 0.37220015 |
| 110 | PIM2 | 0.34967611 |
| 111 | ATR | 0.32829739 |
| 112 | PDGFRA | 0.32604691 |
| 113 | PDK1 | 0.32114523 |
| 114 | PRKAA2 | 0.31610986 |
| 115 | MAP3K3 | 0.31532661 |
| 116 | NEK2 | 0.30531817 |
| 117 | PKN1 | 0.30247479 |
| 118 | HIPK2 | 0.29495645 |
| 119 | MST1R | 0.29306696 |
| 120 | MAP3K7 | 0.28510360 |
| 121 | LATS1 | 0.28137212 |
| 122 | MELK | 0.27671830 |
| 123 | PDPK1 | 0.27037396 |
| 124 | MST4 | 0.25571147 |
| 125 | SCYL2 | 0.25537403 |
| 126 | RPS6KA5 | 0.25127946 |
| 127 | INSR | 0.24350406 |
| 128 | SGK1 | 0.24324931 |
| 129 | MAP3K8 | 0.24059683 |
| 130 | FYN | 0.21874586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Measles_Homo sapiens_hsa05162 | 2.90330969 |
| 2 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.89797640 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85407678 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.72072175 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.69646876 |
| 6 | Influenza A_Homo sapiens_hsa05164 | 2.57370196 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.36506033 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30370370 |
| 9 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.17625033 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15426711 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11906724 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09423720 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03841062 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95401192 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90619203 |
| 16 | Hepatitis C_Homo sapiens_hsa05160 | 1.86925908 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.85733147 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.81639290 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.78684321 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.73211070 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69880801 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62694004 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.61997591 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61170936 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.58732703 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.56606785 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55565258 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.50993839 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47766546 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39381544 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30028854 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28798048 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23516027 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23016348 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21363285 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20261381 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.19800914 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18990407 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18878643 |
| 40 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17774753 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16136291 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15426221 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14965183 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.10419498 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04247654 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02367655 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.01545729 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99777104 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98703560 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96321477 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 0.94440993 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93554083 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92825251 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.89026393 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.87779552 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85971727 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.85462324 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83202613 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.82859507 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82100279 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79933946 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.79866639 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78043105 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.76918380 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75054300 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73992123 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73257304 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72847886 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72331954 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71568685 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71130476 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69284876 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.68909555 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66088672 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65900638 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65683913 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65587655 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63375953 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61517878 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.61494354 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61195394 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58142240 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58088128 |
| 84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57531688 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56799716 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55597833 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55391023 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55108897 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53869949 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52479781 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.48343929 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48276784 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47595835 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47388264 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46862065 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.46472153 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44189409 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43421639 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39928664 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39908692 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.39483878 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38496045 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37841129 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37663558 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36323705 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35150552 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34681377 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.34428755 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34110841 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.31704928 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29379669 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29273943 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25162226 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24912574 |

